FindTrial
Sign In

Analysis on pathogenic bacteria, drug resistance analysis and risk factors of postoperative infection in patients with non-small cell lung cancer

Analysis on pathogenic bacteria, drug resistance analysis and risk factors of postoperative infection in patients with non-small cell lung cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100049575
Enrollment
Unknown
Registered
2021-08-03
Start date
2017-01-01
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

infected:Nil
Without infection group:Nil

Sponsors

Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) The family members are aware of and agree to this study, and have signed the relevant informed consent; (2) The clinical data is complete; (3) All patients are diagnosed as non-small cell lung cancer patients by clinical manifestations and imaging tests.

Exclusion criteria

Exclusion criteria: (1) patients with other tumors; (2) patients with infection before treatment; (3) lost to follow-up; (4) patients with mental illness.

Design outcomes

Primary

MeasureTime frame
The pathogenic bacteria and drug resistance of postoperative non-small cell lung cancer patients infected patients were analyzed.;—

Countries

China

Contacts

Public ContactChen Yan

Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China

chengyan11y@163.com+86 13808075980

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026